News

09.09.2016

CIMT 2017 Annual Meeting

As a special event for its members, CIMT will hold a "Membership Symposium" celebrating 15 years of cancer immunotherapy education and networking. The symposium will take place on May 10-11, in Mainz, Germany.

more

A scientific and social event for the CIMT members community, the symposium will also be the venue for the first "CIMT Lifetime Achievement Award" ceremony.  

07.06.2016

Save the date

The 2017 International Cancer Immunotherapy Conference, "Translating Science Into Survival", will be held in Mainz, Germany, September 6-8.

more

The 2017 meeting will be jointly hosted by CIMT and the Cancer Research Institute (CRI), the European Academy of Tumor Immunology (EATI) and the American Association for Cancer Research (AACR).

12.05.2016

2016 Poster Award Winners

With the generous support of sposoring industry leaders, CIMT awarded the best posters and poster presentations in six categories. CIMT congratulates Mark Gorris (Netherlands), Nina Eissler (Sweden), Anett Pfeiffer (Germany), Amalie Kai Bentzen (Denmark), Heleen Dewitte (Belgium), Ayse Nur Menevse (Germany).

more

Cellular Therapy
sponsored by Merck:
Anett Pfeiffer (Germany)
#114 „Towards in vivo delivery of chimeric antigen receptors“

Immunomonitoring
sponsored by CIMT Immunoguiding Program (CIP):
Amalie Kai Bentzen (Denmark)
#140 „Next generation detection of cancer-responsive T cells using DNA barcode-labeled peptide Major Histocompatvility Complex I multimers“

Therapeutic Vaccination
sponsored by Immatics Biotechnologies:
Heleen Dewitte (Belgium)
#019 „The bubble breakthrough in cancer immunotherapy: mRNA sonoporation in dendritic cell based cancer vaccination“

New Targets & New Leads
sponsored by Ganymed Pharaceuticals:
Ayse Nur Menevse (Germany)
#193 „Discovering novel targets in high-throughput fashion: RNAi screen for pancreatic ductal adenocarcinoma (PDAC) associated immune modulators

Tumor Biology & the Interaction with the Immune System
sponsored by TRON
Mark Gorris (Netherlands)
#276 „Development of multiplex fluorescent ICH immune cell panels to predic immunotherapy outcome“

Improving Immunity
sponsored by BioNTech AG
Nina Eissler (Sweden)
#224 „Release of IFN-
y induced chemokines provides the key to efficient combination immunotherapy of anti-PD-1 atibody with CSF-1R inhibitor“

 

CIMT 2016 Poster Prize Winner

10.05.2016

Europe’s largest cancer immunotherapy meeting opens in Mainz, Germany, with over 1000 participants

Mainz, Germany, May 10, 2016– The Association for Cancer Immunotherapy (CIMT) welcomes the international cancer immunotherapy community at its 2016 Annual Meeting in Mainz, Germany from May 10-12, 2016. Under the headline “Mechanisms of Efficacy”, this year's meeting brings together more than 1000 academic and clinical professionals from 40 countries.

more

Mainz, Germany, May 10, 2016– The Association for Cancer Immunotherapy (CIMT) welcomes the international cancer immunotherapy community at its 2016 Annual Meeting in Mainz, Germany from May 10-12, 2016. Under the headline “Mechanisms of Efficacy”, this year's meeting brings together more than 950 academic and clinical professionals from 40 countries.

The 2016 meeting offers plenary sessions on the topics of tumor vaccination, cellular therapy, improving immunity, immunoguiding, regulatory research, tumor microenvironment, personalized immunotherapy, and a dedicated Voice of the Patient session. 

“After a surge of recent approvals and promising clinical studies, we now see immunotherapies included in the standard of cancer care”, says CIMT President, Prof. Christoph Huber. “As we see therapeutic effects, we now face the challenge of further elucidating the mechanism of efficacy for these therapeutic breakthroughs in order to carefully integrate them into standard treatment protocols. At the CIMT Annual Meeting will hear from world-renowned leaders in the field how the treatment options for patients are being expanded by including immunotherapies.” 

With close to 1000 participants, the CIMT Annual Meeting in Mainz, Germany, is the largest European meeting for cancer immunotherapy. 

As every year, CIMT also gives young investigators the opportunity to present their work to a large international audience. Chosen from 320 entries, 40 abstracts are presented as short talks. 25 travel awards were given to young scientists from Italy, Finland, Turkey, Portugal, Cuba, New Zealand, Israel, Belgium, Denmark and Switzerland. 

In addition to the main scientific program, and in cooperation with the regional Cluster of Individualized ImmuneIntervention (Ci3), CIMT hosts Endeavour, a business workshop on the translation and commercialization of cancer immunotherapies and diagnostics. The meeting is accompanied by an industry exhibition with more than 40 presenting companies.

The 2016 CIMT Annual Meeting is supported by the Federal Ministry of Education and Research.

CIMT 2016 Annual Meeting

09.05.2016

Online registration is closed

The online registration has been closed. There is still the possibility of registering on-site, at the Rheingoldhalle conference center.

more

The online registration has been closed. There is still the possibility of registering on-site, at the Rheingoldhalle conference center.

18.04.2016

Short talk program now online

From more than 300 submitted abstracts, the abstract committee selected 33 authors to present their research as short talks as part of the CIMT scientific program. 

more

The seven short talk sessions will take place on day 2 and 3 of the conference. To view the authors and other details of the short talk sessions, go to http://www.meeting.cimt.eu/program#domvalue_640

05.04.2016

CIMT Social Event sold out

The Social Event on May 11 is SOLD OUT. Registrants interested in being added to the waitlist, please contact Kristina Lang at k.lang@mainzplus.com.

more

The Social Event on May 11 is SOLD OUT. Registrants interested in being added to the waitlist, please contact Kristina Lang at k.lang@mainzplus.com.

29.03.2016

Early registration ends March 31

A 10% surcharge on the quoted fees will be billed for registration after March 31, 12 midnight (Central European Time). An extra fee of 50 EUR for on-site registration applies.

 

more

Abstract authors will be notified before March 31.

Spaces for the CIMT Endeavour workshop are limited.

21.03.2016

Abstract notification after March 29

Because of the high number of submitted abstracts, the abstract notification has been pushed to March 30. The CIMT early registration ends on March 31 at 12 midnight (Central European Time).

more

Because of the high number of submitted abstracts, the abstract notification has been pushed to March 30. The CIMT early registration ends on March 31 at 12 midnight (Central European Time).

29.02.2016

The Economist reports on research results to be presented by CIMT speaker Per thor Straten

The British news magazine The Economist has reported on the beneficial effects of exercise on tumor growth as demonstrated by a team of researchers at the University of Copenhagen and Copenhagen University Hospital. At CIMT 2016, the paper’s co-author Per thor Straten will present the results recently published in Cell Metabolism.  

more

The British news magazine The Economist has reported on the beneficial effects of exercise on tumor growth as demonstrated by a team of researchers at the University of Copenhagen and Copenhagen University Hospital. (“Exercise protects against cancer. Researchers now understand why”). At CIMT 2016, the paper’s co-author Per thor Straten will present the results recently published in Cell Metabolism that suggest that epinephrine and interleukin-6 could be used as anti-tumor drugs. The study’s authors demonstrate that exercise, cancer, and immunity decrease tumor incidence and growth by over 60% across several mouse tumor models through a direct regulation of NK cell mobilization and trafficking in an epinephrine- and IL-6-dependent manner.
Per thor Straen will speak in Session 2 "Improving Immunity" on May 10, 13:30-15:00.

Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution
Line Pedersen, Manja Idorn, Gitte H. Olofsson,2 Britt Lauenborg, Intawat Nookaew, Rasmus Hvass Hansen,Helle Hjorth Johannesen, Jürgen C. Becker, Katrine S. Pedersen, Christine Dethlefsen, Jens Nielsen, Julie Gehl, Bente K. Pedersen, Per thor Straten, and Pernille Hojman. Pedersen et al., 2016, Cell Metabolism 23, 1–9. March 8, 2016. 

A run a day keeps the tumour at bay. Exercise protects against cancer. Researchers now understand why. The Economist. Feb 27, 2016.

 

26.02.2016

CIMT 2016 abstract submission deadline extended

For late -breaking abstracts, the abstract submission deadline has been extended to Friday, March 4 (midnight CET).

Applications for travel awards of 300 EUR plus free conference admission are still accepted.

more

For late-breaking abstracts, the abstract submission deadline has been extended to Friday, March 4 (midnight CET).

Applications for travel awards of 300 EUR plus free conference admission are still accepted.

28.01.2016

New office address

The CIMT offices are moving to a different address. Between January 29 and February 2, CIMT will have limited access to e-mail and phone services. We will answer all inquiries as soon as technically possible. Our phone numbers and e-mail address will not change.

more

The CIMT offices are moving to a different address. Between January 29 and February 2, CIMT will have limited access to e-mail and phone services. We will answer all inquiries as soon as technically possible. Our phone numbers and e-mail addresses will not change.

Our new address, starting February 1:

Association for Cancer Immunotherapy (CIMT)/ IKT e.V.
Hölderlinstrasse 8
55131 Mainz (Germany)

18.01.2016

Conference registration has started

The 2016 online registration is now open. Click here to register for the 14th Annual Meeting of the Asociation for Cancer Immunotherapy.

more

The 2016 online registration is now open. Click here to register for the 14th Annual Meeting of the Asociation for Cancer Immunotherapy.

07.12.2015

2016 Abstract Submission is now open

The CIMT program committee is calling for abstract submissions in the categories Therapeutic Vaccination, New Targets & New Leads, Tumor Biology & Interaction with the Immune System, Immunomonitoring, Cellular Therapy, Improving Immunity.

more

The CIMT program committee is calling for abstract submissions in the categories Therapeutic Vaccination, New Targets & New Leads, Tumor Biology & Interaction with the Immune System, Immunomonitoring, Cellular Therapy, Improving Immunity.

All accepted abstracts will be presented as posters. Selected abstracts will be presented as short talks. The abstract submission deadline will be February 26, 2016.

Go to http://www.abstractserver.de/cimt2016/absmgm/ to submit your abstract.

22.09.2015

CIMT 2015 Annual Meeting Report published

A meeting report on the 2015 CIMT Annual Meeting has been published in the July issue of Human Vaccines & Immunotherapeutics and is now available through open access.

more

A meeting report on the 2015 CIMT Annual Meeting has been published in the July issue of Human Vaccines & Immunotherapeutics and is now available through open access. 

In the report, Kranz et al. summarize the meeting highlights and conclude that in addition to the fast growing field of neoepitope prediction and personalized therapy, the power of checkpoint blockade and especially targeting the PD-1/PD-L1 axis was impressively demonstrated at CIMT 2015. The authors point out that the intelligent combination of personalized immunotherapies targeting individual, tumor-specific neoepitopes with immuno- and/or tumor modulating antibodies may eventually shift the progressing imbalance between immune system and tumor in favor of the former. 

Go to Human Vaccines & Immunotheapies to read the full report.

Kranz L.,  Birtel M., Krienke C., Grunwitz C., Petschenka J.,  Reuter K., van de Roemer N., Vascotto F., Vormehr M., Kreiter S., Diken M. CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy. Human Vaccines & Immunotherapeutics. July 2015.

07.07.2015

Save the date

The next CIMT Annual Meeting will take place in Mainz, Germany, May 10-12, 2016.

more

The next CIMT Annual meeting will take place in Mainz, Germany, May 10-12, 2016.

 

13.05.2015

CIMT 2015 Poster Award Winners

Mainz, May 13, 2015- The CIMT poster jury has announced the winners of the 2015 poster awards. The awards were presented during the closing ceremony of the CIMT Annual Meeting.

more

Mainz, May 13, 2015- The CIMT poster jury has announced the winners of the 2015 poster awards. The awards were presented during the closing ceremony of the CIMT Annual Meeting. CIMT congratulates the winners in the following categories:


Therapeutic Vaccination
Ionna Milenova  (Sweden)
#41 Immunotherapy with a CD40L/4-1BBL double-armed oncolytic adenovirus drives Th1 immunity and controls tumor progression in a pancreatic cancer model

New Targets & Leads
Martin Treder  (Germany)
#83 EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors

Improving Immunity
Kalet Leon  (Cuba)
#129 Therapeutic combination of immunetherapies targeting
NGcGM3 and EGFR to treat cancer

Cellular Therapy
Simon Loff  (Germany)
#156 A novel modular retargeting platform technology for precise control of CAR T cell reactivity

Immunological Monitoring
Sofie Ramskov Andersen  (Denmark)
#230 Identification of novel T cell epitopes in breast cancer

Tumor Biology & Interaction with the Immune System
Sabrina Kirchleitner  (Germany)
#247 RIG-I-like helicase-mediated reprogramming of myeloid-derived suppressor cells as novel therapeutic strategy for pancreatic cancer


The 2015 poster awards were supported by TRON, Boehringer Ingelheim, immatics biotechnologies, BioNTech, Ganymed Pharmaceuticals and the CIMT Immunoguiding Program (CIP).

 

11.05.2015

CIMT Annual Meeting Opened in Mainz with 840 Participants

Mainz, Germany, May 11, 2015 – The Association for Cancer Immunotherapy (CIMT) today opened its 2015 Annual Meeting in Mainz, Germany.  Under the headline “The right patient for the right therapy”, this year's meeting, which runs from May 11-13, 2015, brings together more than 860 academic and clinical professionals from over 30 countries.

 

more

Mainz, Germany, May 11, 2015 – The Association for Cancer Immunotherapy (CIMT) today opened its 2015 Annual Meeting in Mainz, Germany.  Under the headline “The right patient for the right therapy”, this year's meeting, which runs from May 11-13, 2015, brings together more than 860 academic and clinical professionals from over 30 countries.
The 2015 meeting offers plenary sessions on the topics of tumor vaccination, cellular therapy, improving immunity, tumor microenvironment, and personalized immunotherapy, a poster exhibit and selected poster short talk sessions.  “As cancer immunotherapies are moving into the clinic, this year’s meeting theme would like to bring attention to the future treatment challenges of every individual patient”, says CIMT President, Prof. Dr. Christoph Huber. “We are constantly increasing our ability to understand why a new drug works in a given patient. We are excited to hear from the leaders in the field how these advances can now be translated into increased effect sizes and more responding patients.”
CIMT also gives young investigators the opportunity to present their work to a large international audience. Chosen from 290 entries, 31 abstracts are presented as short talks. More than 20 travel awards were given to young scientists from Italy, The Netherlands, Japan, Turkey, Chile, UK, Argentina, Switzerland, Cuba, Hungary, Belgium, India, Finland, Greece and Egypt.
In addition to the main scientific program, CIMT hosts an international Immunoguiding Symposium as well as Endeavour, a business workshop on the translation and commercialization of cancer immunotherapies and diagnostics.  The meeting is accompanied by an industry exhibition with more than 30 presenting companies.
 

Downloads:
213_CIMT_150511.JPG

29.04.2015

Online registration ends May 4

The online conference registration is open through May 4, midnight (CET).

more

The online conference registration is open through May 4, midnight (CET).

24.04.2015

Download the complete program

The complete 2015 Annual Meeting program and abstract books are now available for download.

more

The complete 2015 Annual Meeting program and abstracts are now available for download. Click below to access the day-to-day schedule, speaker profiles, industry exhibitors and scientific abstracts.

2015 Program and Abstracts

09.04.2015

2015 Travel Award Winners

CIMT is pleased to present a total of 20 travel awards to young scientists from Italy, The Netherlands, Japan, Turkey, Chile, UK, Argentina, Switzerland, Cuba, Hungary, Belgium, India, Finland, Greece and Egypt. The 2015 travel awards are supported by grants from immatics biotechnologies and BioNTech AG.

more

CIMT is pleased to present a total of 20 travel awards to young scientists from Italy, The Netherlands, Japan, Turkey, Chile, UK, Argentina, Switzerland, Cuba, Hungary, Belgium, India, Finland, Greece and Egypt.
The award is designed to offset expenses incurred for traveling to the CIMT Annual Meeting. CIMT looks forward to their poster presentations. The 2015 travel awards are supported by grants from immatics biotechnologies and BioNTech AG.

26.03.2015

Early registration ends April 3

Register now for the CIMT Annual Meeting, May 11-13. 
A 10% surcharge on the quoted fees will be billed for registration after April 3, 2015. Abstract authors will be notified by March 31!

more

Register now for the CIMT Annual Meeting, May 11-13. 
A 10% surcharge on the quoted fees will be billed for registration after April 3, 2015. An extra fee of 50 EUR for on-site registration applies.
Abstract authors will be notified by March 31!

We offer a 10% discount on each ticket for group registrations of 10 attendees and more. For group registrations, please contact Ms. Kristina Lang at k.lang@mainzplus.com

Please note that spaces for the CIP symposium on May 11 are limited.

02.03.2015

Abstract submission extended

The 2015 abstract submission has been extended through Friday, March 6 (midnight, CET).

more

The 2015 abstract submission has been extended through Friday, March 6 (midnight, CET).

24.02.2015

CIMT Endeavour Workshop

The 2015 CIMT Endeavour workshop will take place as part of the CIMT Annual Meeting and will provide an opportunity for scientists to discuss their research findings in terms of their future business potential. International business experts in the fields of cancer immunotherapy, intellectual property and commercialization will give advice on translating science into products.  

more

The 2015 CIMT Endeavour workshop will take place as part of the CIMT Annual Meeting and will provide an opportunity for scientists to discuss their research findings in terms of their future business potential. International business experts in the fields of cancer immunotherapy, intellectual property and commercialization will give advice on translating science into products. In addition, leading scientists from biotech companies in the field of cancer immunotherapy will share their stories. The workshop is open to all CIMT Annual Meeting participants and the interested public. Download the Endeavour program and see http://endeavour.cimt.eu/ for more information

The registration fee of 50 EUR includes lunch, snacks and drinks. A registration discount of 20 EUR will be given to participants already registered for the CIMT Annual Meeting. 

CIMT Endeavour 2015 is organized in cooperation with Ci3High Tech Corporate Services, and Oslo Cancer Cluster, and is supported by a grant fromt he German Ministry of Education and Science (BMBF).

Interested scientists from the CIMT Annual Meeting community can submit a research abstract for the CIMT 2015 Endeavour workshop via the CIMT 2015 abstract submission system through February 27. Click here to register for CIMT Endeavour.

For more information, please go to http://endeavour.cimt.eu/ or contact office@cimt.eu

06.02.2015

2015 Registration is open

Take advantage of early-registration fees for CIMT 2015. After April 3, 2015, a 10% surcharge will apply. Klick here to register today.

more

Take advantage of early-registration fees for CIMT 2015. After April 3, 2015, a 10% surcharge will apply. Klick here to register today.

03.02.2015

CIMT Immunoguiding Symposium

On May 11, the CIMT Immunoguiding Program (CIP) will hold a pre-congress symposium, also at Rheingoldhalle Congress Center. Titled “Computational Tools for Biomarker Discovery”, the symposium will focus on computational approaches to complex data set analysis.

more

On May 11, the CIMT Immunoguiding Program (CIP) will hold a pre-congress symposium, also at Rheingoldhalle Congress Center. Titled “Computational Tools for Biomarker Discovery”, the symposium will focus on computational approaches to complex data set analysis. The CIP program committee has invited speakers from Memorial Sloan Kettering, NIH, British Columbia Cancer Agency and Charles University Prague to discuss how these new approaches assist the discovery of novel biomarkers that benefit patient care. The symposium is open to all CIP members and CIMT meeting participants.

Downloads:
CIMT_CIP_Symposium_2015.pdf

27.01.2015

Travel Grants

CIMT offers young scientists from underrepresented countries for travel grants to the 2015 CIMT Annual Meeting.Support includes money for travel and free registration. The application deadline is set for February 27.

The 2015 CIMT Travel Award is supported by immatics and BioNTech. 

more

CIMT selects young scientists from underrepresented countries for travel awards of 300 EUR plus free conference admission to offset meeting-related expenses. Last year’s travel award winners came from Singapore, Ukraine, New Zealand, Brazil, and Cuba, among others. 

Travel awards can only be issued to scientists who have submitted an abstract and are registered to attend the meeting.See the following guidelines to increase your chances of being considered for a travel award:

  • Submit your abstract.
  • Register for CIMT 2015.
  • As a single PDF document, send us your curriculum vitae, including your name, address, e-mail and cell phone number, institution, earned degrees, current degree program, honors and awards, research experience, and a list of publications and previous presentations. Include a short biographical sketch and description of your scientific interests and goals. Attach a letter from your supervisor providing a recommendation, and a confirmation that the research presented was conducted by you or explaining your specific role in the research presented. Don’t forget to include your abstract title as submitted to CIMT 2015. Send your complete application tooffice@cimt.eu, Re: 2015 Travel Award.

Please contact office@cimt.eu for more information.

The 2015 CIMT Travel Award is supported by immatics and BioNTech.

08.12.2014

Abstract submission is now open

The CIMT program committee is calling for abstract submissions in the categories Therapeutic Vaccination, New Targets & New Leads, Tumor Biology & Interaction with the Immune System, Immunomonitoring, Cellular Therapy, Improving Immunity.

more

The CIMT program committee is calling for abstract submissions in the categories Therapeutic Vaccination, New Targets & New Leads, Tumor Biology & Interaction with the Immune System, Immunomonitoring, Cellular Therapy, Improving Immunity.

All accepted abstracts will be presented as posters. Selected abstracts will be presented as short talks. The abstract submission deadline will be February 27, 2015.

Go to http://www.abstractserver.com/cimt2015/absmgm/ to submit your abstract.

18.11.2014

Call for Abstracts

Submit your abstract and participate in Europe's largest expert meeting on cancer immunotherapy research and development. Abstract submission will open December 8.

more

CIMT 2015 - Call for Abstracts

13th Annual Meeting of the Association for Cancer Immunotherapy
"The right patient for the right therapy"
May 11-13 2014 in Mainz, Germany

Submit your abstract and participate in Europe's largest expert meeting on cancer immunotherapy research and development. Abstract submission will open December 8.
The abstract committee is calling for abstract submissions in the sub-specialties of:
Therapeutic Vaccination, Immunomonitoring, Cellular Therapy, New Targets & New Leads, Tumor Biology and Interaction with the Immune System, Improving Immunity, Cellular Therapy, New Targets & New Leads
All accepted abstracts will be presented as posters. Selected abstracts will be presented as short talks. 

11.11.2014

2015 Keynote Lecture

Alexander Eggermont, Director General of France's Institut Gustave Roussy, will give the keynote lecture of the 2015 CIMT Annual Meeting.  

more

Eggermont is Professor of Surgical Oncology and Professor of International Networking in Cancer Research at the Erasmus University Medical Centre in Rotterdam. He holds the ‘Joseph Maisin Chair in Oncology at the Catholic University of Leuven in Belgium. In 1987 he obtained his PhD on ‘Interferon and IFN-Inducers in the Treatment of Cancer’ at the Erasmus University Rotterdam and is a former Fellow of the NCI Surgery Branch, NIH, Bethesda, USA.

His clinical specialties include melanoma, sarcoma and regional therapy techniques as well as general drug development and clinical trial methodology. He is a past Chair of the EORTC MG Group and current Chair of the Adjuvant Therapy Committee EORTC Melanoma Group. His basic research field is in tumor immunology, advanced imaging models and tumor pathophysiology.

Professor Eggermont is the author or co-author of over 600 peer-reviewed publications, book chapters and monographs. More than 30 PhD theses have originated in his clinical and basic laboratory research programs at the Erasmus University MC Rotterdam.

 

31.10.2014

F1000 Posters

View some fantastic posters from the 2014 CIMT Annual Meeting on F1000 Posters. More than 321 abstracts were presented at CIMT 2014.

more

View some fantastic posters from the 2014 CIMT Annual Meeting on F1000 Posters. More than 321 abstracts were presented at CIMT 2014.

F1000Posters is an open access repository that provides a permanent, structured environment for the deposition of posters and slide presentations as well as a trustworthy venue for ongoing discussion and development of the information being presented.
The early scientific information presented in conference presentations is universally agreed to be an important resource but, unfortunately, it is almost always completely lost once a conference is over. As a result, the work is only viewed by a handful of people before it disappears, either forever or until the research is later published as a paper. F1000Posters enables researchers to maximize the value of their presented work by dramatically increasing access and by helping to prevent lengthy delays before others can benefit from new research. The feedback gained by scientists from such early dissemination may help direct future work and also may reduce the duplication of effort between labs and departments, whether by speeding progress towards a similar goal or by preventing the replication of work that has previously failed.

F1000 Posters

CIMT

The Association for Cancer Immunotherapy

Welcome to Europe’s largest meeting focused on cancer immunotherapy research and development.

CIMT is a members-based information and education platform that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. CIMT was founded in 2002 by physicians and researchers from different fields of clinical and theoretical medicine as an independent non-profit organization. CIMT has its offices in Mainz, Germany, and is financed by donations, congress fees, industry sponsorship and by public and foundation grants.

Visit the CIMT website | www.cimt.eu